Age | 63 ± 10yo |
---|---|
Gender (% male) | 31% (12) |
Known CAD | 56% (22) |
Pulmonary Hypertension | 51% (20) |
Atherosclerosis Risk Factors | |
Tobacco Use (prior or current) | 46% (18) |
Hypertension | 67% (26) |
Hyperlipidemia | 54% (21) |
Diabetes mellitus | 18% (7) |
Medication Regimen | |
ACE Inhibitors or ARB | 51% (20) |
Beta-Blockers | 72% (28) |
Aspirin | 74% (29) |
Statin | 69% (27) |
Diuretic | 46% (18) |
Cardiac Structure/Function | |
LVEF (%) | 49 ± 14% |
LV Dysfunction (EF < 50%) | 49% (19) |
LV End-Diastolic Volume | 186 ± 57 ml |
LV End-Systolic Volume | 106 ± 56 ml |
RV EF (%) | 51 ± 11% |
RV Dysfunction (EF < 50%) | 31% (12) |
RV End-Diastolic Volume | 169 ± 62 ml |
RV End-Systolic Volume | 96 ± 52 ml |